Patrys Limited (ASX:PAB)
0.0350
-0.0030 (-7.89%)
Mar 4, 2026, 3:22 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 20.34 million as of March 3, 2026. Its market cap has increased by 147.20% in one year.
Market Cap
20.34M
Enterprise Value
18.44M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 20.34M, a decrease of -79.04%. That is a compound annual growth rate of -8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 20.34M | 113.24% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Argenica Therapeutics | 28.90M |
| Algorae Pharmaceuticals | 27.33M |
| Noxopharm | 19.97M |
| Neurotech International | 16.85M |
| Tissue Repair | 10.88M |
| AdAlta | 10.20M |